[HTML][HTML] Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)
DG Ahn, HJ Shin, MH Kim, S Lee, HS Kim… - … of microbiology and …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), which causes serious respiratory illness
such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei …
such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei …
Covid‐19 and dengue: double punches for dengue‐endemic countries in Asia
Summary The coronavirus disease 2019 (Covid‐19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is an international public health crisis …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is an international public health crisis …
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
The recent outbreak of the betacoronavirus SARS-CoV-2 has become a significant concern
to public health care worldwide. As of August 19, 2020, more than 22,140,472 people are …
to public health care worldwide. As of August 19, 2020, more than 22,140,472 people are …
A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease …
Autophagy (self-eating) is a conserved cellular degradation process that plays important
roles in maintaining homeostasis and preventing nutritional, metabolic, and infection …
roles in maintaining homeostasis and preventing nutritional, metabolic, and infection …
COVID-19 pandemic and vaccines update on challenges and resolutions
The coronavirus disease (COVID-19) is caused by a positive-stranded RNA virus called
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
Microstructure, pathophysiology, and potential therapeutics of COVID‐19: a comprehensive review
There have been over seven million cases and almost 413 372 deaths globally due to the
novel coronavirus (2019‐nCoV) associated disease COVID‐19, as of 11 June 2020 …
novel coronavirus (2019‐nCoV) associated disease COVID‐19, as of 11 June 2020 …
Dengue fever, COVID‐19 (SARS‐CoV‐2), and antibody‐dependent enhancement (ADE): a perspective
SARS‐CoV‐2 pandemic and recurrent dengue epidemics in tropical countries have turned
into a global health threat. While both virus‐caused infections may only reveal light …
into a global health threat. While both virus‐caused infections may only reveal light …
Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection
R Narayan, S Tripathi - Frontiers in cellular and infection microbiology, 2020 - frontiersin.org
Dengue fever is an Aedes mosquito-borne illness caused by any one of the four different
dengue virus (DENV) serotypes (1–4) and manifests in the form of symptoms ranging from …
dengue virus (DENV) serotypes (1–4) and manifests in the form of symptoms ranging from …
Spike-dependent opsonization indicates both dose-dependent inhibition of phagocytosis and that non-neutralizing antibodies can confer protection to SARS-CoV-2
W Bahnan, S Wrighton, M Sundwall… - Frontiers in …, 2022 - frontiersin.org
Spike-specific antibodies are central to effective COVID19 immunity. Research efforts have
focused on antibodies that neutralize the ACE2-Spike interaction but not on non-neutralizing …
focused on antibodies that neutralize the ACE2-Spike interaction but not on non-neutralizing …
Role of Fc core fucosylation in the effector function of IgG1 antibodies
The presence of fucose on IgG1 Asn-297 N-linked glycan is the modification of the human
IgG1 Fc structure with the most significant impact on FcɣRIII affinity. It also significantly …
IgG1 Fc structure with the most significant impact on FcɣRIII affinity. It also significantly …